Vistica Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vistica Wealth Advisors's BMY Position: Q2 2026 in Review
Vistica Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $45.4K and leaving 3,731 shares worth $215K. The position accounts for 0.19% of the portfolio, ranked #51.
Vistica Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $274K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vistica Wealth Advisors held 3,731 shares of Bristol-Myers Squibb worth $215K as of Q2 2026.
- Vistica Wealth Advisors sold 790 Bristol-Myers Squibb shares in Q2 2026, an estimated $45.4K.
- Bristol-Myers Squibb made up 0.19% of Vistica Wealth Advisors's portfolio in Q2 2026, its #51 holding.
- Vistica Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Vistica Wealth Advisors's Bristol-Myers Squibb position peaked at $274K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vistica Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.